TLRY
Price
$1.21
Change
-$0.01 (-0.82%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
1.36B
15 days until earnings call
Interact to see
Advertisement

TLRY

Header iconTLRY Comparison
Open Charts TLRYBanner chart's image
Tilray Brands
Price$1.21
Change-$0.01 (-0.82%)
Volume$137.27K
Capitalization1.36B
TLRY Comparison Chart in %
Loading...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Bausch Health Companies (NYSE:BHC), BioCryst Pharmaceuticals (NASDAQ:BCRX), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Tilray Brands (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

Market Cap

The average market capitalization across the Pharmaceuticals: Generic Industry is 3.89B. The market cap for tickers in the group ranges from 5.57K to 65.35B. ZTS holds the highest valuation in this group at 65.35B. The lowest valued company is BGPPF at 5.57K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Generic Industry was 26%. For the same Industry, the average monthly price growth was 26%, and the average quarterly price growth was 60%. INNPD experienced the highest price growth at 5,793%, while RGTLF experienced the biggest fall at -91%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Generic Industry was -14%. For the same stocks of the Industry, the average monthly volume growth was -34% and the average quarterly volume growth was -2%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 65
Price Growth Rating: 55
SMR Rating: 83
Profit Risk Rating: 91
Seasonality Score: -21 (-100 ... +100)
Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (TLRY: $1.21)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TLRY’s FA Score shows that 0 FA rating(s) are green while.

  • TLRY’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TLRY’s TA Score shows that 4 TA indicator(s) are bullish.

  • TLRY’s TA Score: 4 bullish, 5 bearish.

Price Growth

TLRY (@Pharmaceuticals: Generic) experienced а +11.01% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +26.07%. For the same industry, the average monthly price growth was +25.64%, and the average quarterly price growth was +59.72%.

Reported Earning Dates

TLRY is expected to report earnings on Oct 02, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+26.07% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLRY
Capitalization1.36B
EBITDA-2.13B
Gain YTD-9.023
P/E RatioN/A
Revenue821M
Total Cash256M
Total Debt329M
FUNDAMENTALS RATINGS
TLRY: Fundamental Ratings
TLRY
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TLRY
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYPMX222.71N/A
N/A
Rydex Precious Metals Inv
MFRBX53.63N/A
N/A
MFS Research B
ARALX15.85N/A
N/A
Aristotle Core Eq A
DSCLX18.43-0.12
-0.65%
DFA International Social Cor Eq Instl
FNEEX74.24-0.52
-0.70%
American Funds New Economy 529-F-2

TLRY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TLRY has been closely correlated with SNDL. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if TLRY jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLRY
1D Price
Change %
TLRY100%
-0.82%
SNDL - TLRY
76%
Closely correlated
N/A
CGC - TLRY
63%
Loosely correlated
-6.21%
OGI - TLRY
60%
Loosely correlated
+0.57%
CRON - TLRY
60%
Loosely correlated
-0.77%
ACB - TLRY
55%
Loosely correlated
-0.20%
More